OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
45
Results
Show all
Save search
Copy query
Show results for
Unknown
(44)
Proteomics
(1)
Organisms
Alphavirus
(1)
Anemia
(1)
Betaherpesvirinae
(1)
Brassica oleracea var. oleracea
(1)
Cowpox virus
(1)
Coxsackievirus
(1)
Cytomegalovirus
(1)
Dengue virus
(1)
EFO:0001352
(1)
Filoviridae
(1)
Hepatitis B virus
(1)
Human alphaherpesvirus 1
(1)
Human betaherpesvirus 5
(1)
Human immunodeficiency virus
(1)
Human immunodeficiency virus 1
(1)
Human immunodeficiency virus 2
(1)
Influenza A virus
(1)
Influenza C virus
(1)
Japanese encephalitis virus
(1)
Japanese encephalitis virus group
(1)
Lyssavirus rabies
(1)
Monkeypox virus
(1)
Orthopoxvirus
(1)
Orthopoxvirus vaccinia
(1)
Rattus
(1)
Ruditapes decussatus
(1)
Staphylococcus aureus
(1)
Tick-borne encephalitis virus
(1)
Viruses
(1)
West Nile virus
(1)
Repository
pride
(1)
Technology Type
Gel-based experiment
(1)
Mass Spectrometry
(1)
Publication Date
2021
(1)
Release Date
2021
(13)
2022
(5)
2015
(5)
2010
(4)
2024
(3)
2023
(3)
2020
(2)
2018
(2)
2016
(2)
2011
(2)
2025
(1)
2017
(1)
2008
(1)
Lab affiliation
Section of Rheumatology and The Knapp Center for Lupus and Immunology Research, Department of Medicine, The University of Chicago, Chicago, IL, USA.
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Target search for self-reactive antibodies in human renal allograft rejection
Self-reactive antibodies cloned from B cells infiltrating in a human renal allograft were subjected to IP-mass spectrometry using nuclear lysates of HEp-2 cells.
ORGANISM(S):
Homo sapiens (Human)
2021-04-27
|
PXD022989
|
Pride
Keywords: renal allograft rejection
Transcription
Q-exactive
Inflammation
Scrna-seq
Human
Human
Innate b cells
Autoantibodies
Lfq
Tolerance
Cite
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy: The ARCADIA Randomized Clinical Trial.
Not available
S-EPMC10851142
|
biostudies-literature
Cite
Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.
Not available
S-EPMC4924347
|
biostudies-literature
Cite
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC11581631
|
biostudies-literature
Cite
A deep learning framework identifies dimensional representations of Alzheimer's Disease from brain structure.
Not available
S-EPMC8642554
|
biostudies-literature
Cite
Topical nepafenec in eyes with noncentral diabetic macular edema.
Not available
S-EPMC4408212
|
biostudies-literature
Cite
Effects of medical therapies on retinopathy progression in type 2 diabetes.
Not available
S-EPMC4026164
|
biostudies-literature
Cite
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Not available
S-EPMC4422053
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial.
Not available
S-EPMC9403849
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
